{
    "nct_id": "NCT06387394",
    "official_title": "BOTOX® (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study",
    "inclusion_criteria": "* Participant meets the following criteria:\n\n  * Bilateral Grade 4 or Grade 5 Masseter Muscle Prominence (MMP) (identical grades for left and right sides of the face), as determined at by the investigator using the Masseter Muscle Prominence Scale (MMPS).\n  * Bilateral Grade 4 or Grade 5 MMP (identical grades for left and right sides of the face), as determined by the participant using the Masseter Muscle Prominence Scale - Participant (MMPS-P).\n  * Investigator and participant scoring of MMPS and MMPS-P must be the same.\n* Body mass index (BMI) ≤ 30 kg/m^2 using the calculation: BMI = weight (kg)/height (m)^2.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Excess lower facial fat, jowling, loose or lax skin in lower face, or parotid gland prominence that could interfere with MMPS or MMPS-P grading.\n* Asymmetry of left and right sides of the face that could prevent identical MMPS or MMPS-P grading on both sides of the face.\n* History of or current temporomandibular disorder (TMJD), or presence of signs/symptoms of possible TMJD.",
    "miscellaneous_criteria": ""
}